TADALAFIL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 12 adverse event reports in the FDA FAERS database where TADALAFIL was used for Psoriasis.
Most Reported Side Effects for TADALAFIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 3,196 | 10.4% | 94 | 781 |
| Drug ineffective | 2,943 | 9.6% | 47 | 199 |
| Dyspnoea | 2,881 | 9.4% | 213 | 1,416 |
| Death | 1,917 | 6.3% | 1,884 | 254 |
| Diarrhoea | 1,667 | 5.4% | 121 | 624 |
| Dizziness | 1,374 | 4.5% | 38 | 415 |
| Nausea | 1,368 | 4.5% | 59 | 494 |
| Asthenia | 1,230 | 4.0% | 44 | 261 |
| Fatigue | 1,135 | 3.7% | 51 | 366 |
| Hypertension | 1,044 | 3.4% | 9 | 129 |
| Off label use | 1,034 | 3.4% | 81 | 294 |
| Pain in extremity | 911 | 3.0% | 29 | 230 |
| Back pain | 898 | 2.9% | 17 | 153 |
| Cough | 898 | 2.9% | 35 | 298 |
| Malaise | 875 | 2.9% | 75 | 404 |
Other Indications for TADALAFIL
Product used for unknown indication (9,275)
Pulmonary arterial hypertension (7,679)
Erectile dysfunction (6,574)
Pulmonary hypertension (2,430)
Benign prostatic hyperplasia (1,154)
Sexual dysfunction (69)
Hypertension (64)
Prostatomegaly (51)
Prostatic disorder (46)
Cor pulmonale chronic (42)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)